中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 10
Oct.  2016

Value of five noninvasive diagnostic techniques and their combinations in diagnosis of liver fibrosis in patients with chronic hepatitis B

DOI: 10.3969/j.issn.1001-5256.2016.10.013
  • Published Date: 2016-10-20
  • Objective To investigate the correlation of aspartate aminotransferase to platelet ratio index( APRI),FIB-4,Forns index,S index,and Fibro Scan with the degree of liver fibrosis,the diagnostic value of these techniques used alone or in combination,and the clinical value of these noninvasive techniques in the assessment of the degree of liver fibrosis in patients with chronic hepatitis B( CHB). Methods A retrospective analysis was performed for the clinical data of 91 patients with pathologically confirmed CHB who visited General Hospital of Ningxia Medical University and underwent liver biopsy from January 2009 to April 2015. According to the Scheuer pathological stage and liver fibrosis stage( S),the patients were divided into non-liver fibrosis group( a liver fibrosis stage of S0,32 patients),mild liver fibrosis group( a liver fibrosis stage of < S2,30 patients),and marked liver fibrosis group( a liver fibrosis stage of ≥S2,29 patients). The APRI,FIB-4,Forns index,and S index were calculated,and liver stiffness was measured by Fibro Scan. An analysis of variance was used for the comparison of normally distributed continuous data between three groups,and the Dunnett t-test was used for further comparison between any two groups. The Spearman correlation analysis was also performed. Sensitivity,specificity,and area under the receiver operating characteristic curve( AUC) were used to evaluate the value of these noninvasive techniques in the diagnosis of liver fibrosis. Results There were significant differences in age,albumin,aspartate aminotransferase,alanine aminotransferase,and platelet count between the three groups( F = 3. 552,4. 035,4. 374,and 5. 992,all P < 0. 05),and there were significant differences in these parameters between the non-liver fibrosis group and the mild and marked liver fibrosis groups( P < 0. 05). There were significant differences in APRI,FIB-4,Forns index,S index,and Fibro Scan between the three groups( F = 4. 579,5. 728,10. 501,14. 118,and 30. 039,all P < 0. 05); there were significant differences in these indices between the non-liver fibrosis group and the mild and marked liver fibrosis groups( P < 0. 05),and there was a significant difference in Fibro Scan between the mild liver fibrosis group and the marked liver fibrosis group( P < 0. 05). APRI,FIB-4,Forns index,S index,and Fibro Scan were positively correlated with the pathological stage of liver fibrosis( r = 0. 499,0. 498,0. 402,0. 395,and 0. 739,all P < 0. 05). APRI,FIB-4,Forns index,S index,or Fibro Scan alone has certain value in the diagnosis of liver fibrosis,with an AUC( 95% CI) of 0. 786( 0. 679-0. 892),0. 818( 0. 717-0. 918),0. 770( 0. 661-0. 880),0. 718( 0. 599-0. 837),or 0. 919( 0. 864-0. 974)( all P < 0. 01). When APRI,FIB-4,Forns index,or S index was combined with Fibro Scan,the AUC( 95% CI) was increased to 0. 922( 0. 868-0. 976),0. 931( 0. 881-0. 981),0. 926( 0. 873-0. 979),and 0. 918( 0. 862-0. 974),respectively. A combination of APRI,FIB-4,Forns index,S index,and Fibro Scan increased the AUC( 95% CI) to 0. 927( 0. 875-0. 979). Conclusion APRI,FIB-4,Forns index,S index,and Fibro Scan are significantly positively correlated with liver fibrosis grade. A combination of these indices can increase the accuracy of the diagnosis of liver fibrosis and has a similar value as pathological diagnosis and a certain value in the early diagnosis of liver fibrosis. Moreover,it can guide the selection of the timing of antiviral therapy in clinical practice.

     

  • [1]PISCAGLIA F,MARINELLI S,BOTA S,et al.The role of ultrasound elstographic techniquesin chronic liver disease:current status and future perspectives[J].Eur J Radiol,2013,83(6):450-455.
    [2]POPESCU A,SPOREA I,SIRLI R.The mean values of liver stiffness assessed by acoustic radiation force impulse elastography in normal subjects[J].Med Ultrason,2011,13(1):33-37.
    [3]Chinese Society of Hepatology,Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.
    [4]Chinese Society of Infectious Diseases and Parasitology&Chinese Society of Hepatology,Chinese Medical Association.Regimens for the prevention and treatment of viral hepatitis[J].Chin J Infect Dis,2001,19(1):56-62.(in Chinese)中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62.
    [5]CHEN W,WENG PJ,GAO GS,et al,Comparison of shear wave velocity with noninvasive serum score systems in diagnosis of liver fibrosis of patients with chronic hepatitis[J].Chin J Clin Infect Dis,2013,6(5):269-272.(in Chinese)陈巍,翁彭剑,高国生,等.剪切波速与四种无创血清评分系统对慢性肝炎患者肝纤维化诊断效果的比较[J].中华临床感染病杂志,2013,6(5):269-272.
    [6]GAO GS,ZHU HC,WENG PJ.Correlation analysis between common laboratory indexes and liver fibrosis of chronic hepatitis B[J].Prac Med,2011,27(2):220-222.(in Chinese)高国生,朱海超,翁彭剑.常用实验室指标与慢性乙型肝炎肝纤维化的相关性分析[J].实用医学杂志,2011,27(2):220-222.
    [7]WAHL K,ROSENBERG W,VASKE B,et al.Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis score compared to transient elastography[J].PLo S One,2012,7(12):e51906.
    [8]SPOREA I,SIRLI R.Hepatic elastography for the assessment of liver fibrosis-present and future[J].Ultraschall Med,2012,33(6):550-558.
    [9]MOHAMADNEJAD M,MONTAZERI G,FAZLOLLAHI A,et al.Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus elated liver disease[J].Gastroenterol,2006,101(9):2537-2545.
    [10]LUO YC,CHEN DL.Correlation of ALT,AST,TBil and liver fibrosis indexes in patients with liver cirrhosis[J].Prac Prev Med,2011,18(8):1542-1543.(in Chinese)罗育春,陈大兰.肝硬化患者血清谷丙转氨酶、谷草转氨酶和总胆红素与肝纤维化标志物的相关性研究[J].实用预防医学,2011,18(8):1542-1543.
    [11]ZHANG YL,ZENG J,FAN QQ,et al.Four noninvasive score systems for diagnosis of liver fibrosis in patients with chronic hepatitis B[J].Chin J Clin Infect Dis,2012,5(6):338-341.(in Chinese)张彦亮,曾娟,范清琪,等.四种评分系统对慢性乙型肝炎患者肝纤维化的预测价值[J].中华临床感染病杂志,2012,5(6):338-341.
    [12]MAO DF,GAO GS,HU YR,et al.The predictive value of shear wave velocity and four noninvasive score systems for diagnosis of early liver cirrhosis in patients with chronic hepatitis B[J].Mod Prac Med,2014,26(11):1382-1384.(in Chinese)毛达峰,高国生,胡耀仁,等.剪切波速与4种评分系统对慢性乙型肝炎患者早期肝硬化的预测价值研究[J].现代实用医学,2014,26(11):1382-1384.
    [13]SONG SY,ZHU XH.Analysis of diagnosis value on S-index evaluating slight chronic hepatitis B fibrosis[J].J Zhejiang Univ Tradit Chin Med,2015,39(3):199-201.(in Chinese)宋诗雅,朱肖鸿.S指数评价轻型慢乙肝肝纤维化程度的诊断价值分析[J].浙江中医药大学学报,2015,39(3):199-201.
    [14]European Association for the Study of the Liver.EASL clinical practice guidelines:Management of chronic hepatitis B virus infection[J].J Hepatol,2012,57(1):167-185.
    [15]HAN Y,SUN L,LIU YM,et al.Clinical significance of pathological examination to patients with chronic hepatitis B having normal or mild abnormal liver transaminases[J].Clin Focus,2011,26(21):1871-1873.(in Chinese)韩莹,孙琳,刘燕敏,等.肝脏病理检查对转氨酶正常及轻度异常的慢性乙型肝炎患者的临床意义[J].临床荟萃,2011,26(21):1871-1873.
    [16]LI ZG.The efficacy of anti-virus of 103 cases of hepatitis B in immune tolerant[J].China Prac Med,2011,6(24):17-18.(in Chinese)李志刚.103例免疫耐受期乙肝患者抗病毒的疗效分析[J].中国实用医药,2011,6(24):17-18.
  • Cited by

    Periodical cited type(22)

    1. 李述美,刘冰,刘仁伟,杨洁. GP73、IL-2R、miR-21预测慢性乙肝患者显著肝纤维化的临床价值. 重庆医学. 2024(23): 3575-3580 .
    2. 许贞贞,李仪,徐冬新. APRI评分、FIB-4指数、GPR指数及RPR指数联合血栓弹力图检测对早期肝硬化的诊断价值. 现代实用医学. 2022(04): 540-541 .
    3. 唐艳芳,刘旭东,赵晓芳,赵壮志,吕萍,徐新杰. 肝脏硬度与慢性乙型肝炎中医证型的关系及联合APRI、FIB-4、GP对肝纤维化的诊断价值. 中西医结合肝病杂志. 2021(04): 312-315 .
    4. 郝泉,冯巩. 进展性非酒精性脂肪性肝病无创性诊断的临床研究进展. 临床医学研究与实践. 2020(01): 196-198 .
    5. 谢春艳,胡景玉,牟娜,郭连峰,张长庚. APRI对慢性乙型肝炎肝脏炎症和纤维化程度的预测性能评价. 中国免疫学杂志. 2020(02): 210-214 .
    6. 王迪,龙世群. Mac-2BP联合FUC-HPT对慢性肝炎患者病情严重程度的诊断价值. 检验医学与临床. 2020(06): 784-787 .
    7. 匡红英,贺建华. APRI FIB-4 GPR RPR无创血清学模型诊断乙肝后肝硬化的应用现状. 基层医学论坛. 2020(26): 3786-3788 .
    8. 龚航,李良平. 进展性非酒精性脂肪性肝病的无创诊断方法. 临床肝胆病杂志. 2019(02): 406-410 . 本站查看
    9. 周保仓,曹亚伟. Firbscan和肝活检在慢性乙肝患者肝纤维化程度诊断价值的比较. 中南医学科学杂志. 2019(03): 264-266+277 .
    10. 刘志威,陈友鹏,何京,李桃源,赵利婷,梁旭竞. 代谢综合征对丙型肝炎病毒感染者肝纤维化进程的研究. 新医学. 2019(09): 691-695 .
    11. 李嘉,邓靖单,张岳农,徐继威,张彩云. APRI、FIB-4、BPRI对原发性肝细胞癌术后复发的预测价值. 中国普通外科杂志. 2019(12): 1547-1551 .
    12. 吴一鸣,高树兴,殷新光. 核素首次通过法测定肝动脉血流指数预测日本血吸虫病肝纤维化程度?. 中国肝脏病杂志(电子版). 2018(02): 49-54 .
    13. 赵文,张思雨,路宇,赵素贤,王荣琦,南月敏. FibroTouch联合FIB-4、APRI及GPRI评估肝纤维化. 临床荟萃. 2018(02): 140-144 .
    14. 王海莉,贾因棠. APRI、GPRI、FIB-4在诊断慢乙肝肝脏纤维化及肝癌中的临床应用价值. 山西医科大学学报. 2018(06): 650-654 .
    15. 魏铁军,张恒,郭艺静,张永利,姜萌,任文生. 慢性丙型肝炎患者血清ATX水平与肝纤维化程度的关系研究. 胃肠病学和肝病学杂志. 2018(07): 734-738 .
    16. 吴一鸣,高树兴,殷新光. 测定肝动脉血流指数预测血吸虫肝纤维化的临床研究. 世界华人消化杂志. 2018(07): 434-440 .
    17. 姚文军,谢群,王文星,胡忠群,柯凌霞. 多项肝纤维化无创诊断模型在乙肝后肝硬化中的诊断效能. 现代医药卫生. 2018(16): 2460-2462+2465 .
    18. 蒋影,姚云清,汪燕,龙玲. Fibroscan、APRI及其联合诊断慢性乙型肝炎肝纤维化(F≥2)价值的meta分析. 现代医药卫生. 2018(19): 2953-2958 .
    19. 程贤文,王振东,崔翔,王新磊,王峰,刘遥顺,张博,华鹏,万文雅,张亚梅,杨涛,赵军,来杰峰,施维群. 中医证型与肝纤维化及细胞因子关系分析. 陕西中医药大学学报. 2018(06): 46-49 .
    20. 吴方雄,高保华,牛春燕,孙娟,汪雯,朱琳,罗建梅,郑建云. APRI评分对慢性乙型肝炎肝纤维化程度的诊断及预测价值. 临床肝胆病杂志. 2017(08): 1483-1486 . 本站查看
    21. 孟艳,隆仙琴,李杰,丁文波. 超声实时组织弹性成像定量分析对肝脏纤维化程度的诊断价值. 中国临床研究. 2017(11): 1549-1551 .
    22. 葛晓卫. 乙型肝炎病毒‐DNA检测在乙型肝炎中的诊断价值研究. 实用妇科内分泌杂志(电子版). 2016(12): 33-34 .

    Other cited types(24)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2440) PDF downloads(485) Cited by(46)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return